Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

Alimera Sciences, Inc.

Chesapeake Eye Care and Laser Center provides ophthalmology services, specializing in surgical techniques for glaucoma and cataract surgery, as well as oculoplastic surgery and medical retina care.

Chesapeake Eye Care and Laser Center

MEDELSIS is a medical device company that provides medical instruments for the highest standards of care, ensuring benefits to both physicians and patients. Self-described as dedicated to working with ophthalmologists.

MEDELSIS

Alimera Sciences is a global pharmaceutical company focused on retinal health and treatments for retinal diseases.

Metric
Company Name	Alimera Sciences, Inc.	Chesapeake Eye Care and Laser Center	MEDELSIS
Symbol	ALIM
MSH ID	COM:ALIMERASCIENCES	COM:CHESAPEAKEEYECARE	COM:MEDELSIS
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Drug Manufacturers - Specialty & Generic	Health Services	Medical Devices
Country	US	US	TR
Stage	Equity	Private Equity
Employee Count	154
Website	alimerasciences.com	chesapeakeeyecare.com	medelsis.com
LinkedIn		chesapeake-eye-care-and-laser-center
Founders

Metric
Market Cap	291.28M
Enterprise Value
Monthly Web Traffic	42.70K	1.49K
Web Traffic Growth	-0.95	-0.41
Valuation
Raised Capital	20M

Metric
Revenue	80.75M
Revenue (LTM)
Revenue (NTM)
Gross Profit	61.17M
EBITDA	7.28M
Operating Income	-1.47M
Net Income	-20.13M
EPS	-0.79
Diluted EPS	-0.79
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.83
Operating Profit Margin	0.01
EBITDA Margin	0.09
Net Profit Margin	-0.15
Return on Equity	-0.34
Return on Assets	-0.10
Return on Capital Employed	0.01

COM:ALIMERASCIENCES

Alimera Sciences Inc.

Last Close

5.55

13/09 20:00

Market Cap

291.28M

Beta: -

Volume Today

2.68M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-5.19
P/B Ratio	2.49
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.25
EV Multiple	122.86

Metric
Days Sales Outstanding	180.92
Days Payables Outstanding	242.59
Days Inventory Outstanding	55.34
Operating Cycle	205.56
Cash Conversion Cycle	27.60
Asset Turnover	0.66

Metric
Operating Cash Flow	-14.26M
Free Cash Flow	-89.79M
Cash Flow to Debt	-0.08
Operating Cash Flow/Sales	-0.06
Free Cash Flow Yield	-0.41

Metric
Cash & Equivalents	12.09M
Accounts Receivable	-17.16M
Inventory	1.88M
Goodwill
Debt to Capitalization	0.64
Debt to Assets	0.42
Current Ratio	2.73
Quick Ratio	2.62

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue	0.23
SG&A to Revenue	0.23